Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.6.4 to v3.6.5, signaling a new minor update to the page. This reflects a metadata or formatting adjustment rather than changes to study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling an administrative update to the record. No study details or data appear to be affected by this change.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page template and does not affect study content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating an updated revision of the page’s documents.SummaryDifference0.1%

- Check58 days agoChange DetectedEnrollment status updated to indicate recruitment is closed. New study-navigation sections and a formatting/version update provide clearer guidance on reading the study record and joining the study.SummaryDifference0.4%

- Check65 days agoChange Detected- The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page version. The update does not imply changes to the study details or core content.SummaryDifference0.1%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.